Biological Skin Substitutes Market Size

Biological Skin Substitutes Market Size

Biological Skin Substitutes Market size was valued at USD 287 million in 2022 and is estimated to account for USD 640 million by 2032. Biological skin substitutes, also known as skin grafts, are medical products used to replace or regenerate damaged or lost skin tissue. Chronic wounds, such as venous leg ulcers, diabetic ulcers and pressure ulcers, are becoming more common.

To get key market trends

  Download Free Sample

For instance, according to the NIH data, there are around 9.1 to 26.1 million new cases of diabetic foot ulcers worldwide each year. These wounds often require advanced wound care solutions such as biological skin substitutes, to promote healing. Therefore, as the prevalence of chronic wounds continues to rise, the demand for biological skin substitutes will also increase.

Furthermore, burn injuries and trauma cases, including accidents and surgeries, often result in complex wounds. Biological skin substitutes offer a valuable solution in such cases by providing a scaffold for tissue regeneration and wound healing. For instance, the National Library of Medicine (NLM) in India reports 6-7 million annual burn cases, while the American Association for the Surgery of Trauma states that the U.S. sees over 150,000 fatalities and 3 million non-fatal injuries annually. Therefore, with the increasing incidence of burn injuries and trauma cases, there is a growing need for effective wound care biologics such as biological skin substitutes.